Roberts Glore & CO Inc Atrion Corp Transaction History

Roberts Glore & CO Inc

$341 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$381.09 - $495.99 $48,398 - $62,990	-127 Reduced 2.47%	5,018 $2.27 Million
Q1 2024 May 09, 2024	SELL	$308.3 - $463.55 $55,802 - $83,902	-181 Reduced 3.4%	5,145 $2.38 Million
Q4 2023 Feb 12, 2024	SELL	$289.29 - $409.7 $72,033 - $102,015	-249 Reduced 4.47%	5,326 $2.02 Million
Q3 2023 Nov 13, 2023	SELL	$401.2 - $581.79 $22,066 - $31,998	-55 Reduced 0.98%	5,575 $2.3 Million
Q2 2023 Aug 14, 2023	SELL	$500.0 - $659.0 $72,000 - $94,896	-144 Reduced 2.49%	5,630 $3.18 Million
Q1 2023 May 08, 2023	SELL	$565.0 - $694.87 $23,165 - $28,489	-41 Reduced 0.71%	5,774 $3.63 Million
Q4 2022 Feb 13, 2023	SELL	$551.1 - $688.5 $133,917 - $167,305	-243 Reduced 4.01%	5,815 $3.25 Million
Q3 2022 Nov 07, 2022	BUY	$545.43 - $680.3 $11,454 - $14,286	21 Added 0.35%	6,058 $3.42 Million
Q2 2022 Aug 11, 2022	BUY	$605.0 - $763.25 $1,815 - $2,289	3 Added 0.05%	6,037 $3.8 Million
Q1 2022 May 02, 2022	BUY	$601.4 - $763.0 $25,860 - $32,809	43 Added 0.72%	6,034 $4.3 Million
Q4 2021 Feb 11, 2022	BUY	$650.15 - $802.0 $54,612 - $67,368	84 Added 1.42%	5,991 $4.22 Million
Q3 2021 Nov 12, 2021	BUY	$594.24 - $758.0 $8,913 - $11,370	15 Added 0.25%	5,907 $4.12 Million
Q2 2021 Aug 10, 2021	BUY	$582.88 - $670.99 $71,694 - $82,531	123 Added 2.13%	5,892 $3.66 Million
Q1 2021 May 06, 2021	BUY	$619.2 - $736.0 $19,814 - $23,552	32 Added 0.56%	5,769 $3.7 Million
Q4 2020 Feb 09, 2021	BUY	$576.6 - $672.2 $142,420 - $166,033	247 Added 4.5%	5,737 $3.68 Million
Q3 2020 Nov 06, 2020	BUY	$620.1 - $689.89 $75,032 - $83,476	121 Added 2.25%	5,490 $3.44 Million
Q2 2020 Aug 13, 2020	SELL	$610.05 - $713.9 $31,112 - $36,408	-51 Reduced 0.94%	5,369 $3.42 Million
Q1 2020 May 11, 2020	BUY	$615.5 - $751.4 $126,793 - $154,788	206 Added 3.95%	5,420 $3.52 Million
Q4 2019 Feb 13, 2020	BUY	$688.5 - $846.15 $1.2 Million - $1.48 Million	1,750 Added 50.52%	5,214 $3.92 Million
Q2 2019 Aug 09, 2019	SELL	$837.83 - $927.0 $15,918 - $17,613	-19 Reduced 0.55%	3,464 $2.95 Million
Q1 2019 May 14, 2019	SELL	$709.9 - $885.4 $80,928 - $100,935	-114 Reduced 3.17%	3,483 $3.06 Million
Q4 2018 Feb 08, 2019	SELL	$667.94 - $785.7 $136,259 - $160,282	-204 Reduced 5.37%	3,597 $2.67 Million
Q3 2018 Nov 09, 2018	BUY	$602.8 - $699.6 $9,644 - $11,193	16 Added 0.42%	3,801 $2.64 Million
Q2 2018 Aug 10, 2018	SELL	$568.25 - $635.8 $22,730 - $25,432	-40 Reduced 1.05%	3,785 $2.27 Million
Q1 2018 May 08, 2018	SELL	$526.8 - $633.85 $18,438 - $22,184	-35 Reduced 0.91%	3,825 $2.42 Million
Q4 2017 Feb 09, 2018	SELL	$620.6 - $689.35 $31,650 - $35,156	-51 Reduced 1.3%	3,860 $2.43 Million
Q3 2017 Nov 08, 2017	SELL	$608.7 - $680.0 $71,217 - $79,560	-117 Reduced 2.9%	3,911 $2.63 Million
Q2 2017 Aug 15, 2017	BUY	N/A	4,028	4,028 $2.59 Million

Others Institutions Holding ATRI

# of Institutions

Shares Held

114K

Call Options Held

Put Options Held

View Full List

About ATRION CORP

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

More about ATRI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account